The company has a promising pipeline with XP-8121, a once-weekly levothyroxine injection for hypothyroidism, showing positive phase 2 data. Despite a decline in Keveyis revenue, Xeris remains a ...

Kristen Fischer has written for numerous health publications, hospitals, and medical companies, and is a member of the Association of Health Care Journalists. Levothyroxine, a common medication ...

Levothyroxine, a cornerstone in treating hypothyroidism, has come under scrutiny as emerging evidence suggests its impact on bone health may be more significant than previously understood ...

Levothyroxine is a frequently prescribed drug in the United States, particularly for older people, as lower thyroid function can be associated with aging. Questions remain over how appropriately ...

Could Synthroid be doing more harm than good? New research links the thyroid medicine to potential bone loss. Dr. Yadal Safai says the study was “quite small” and that “much more research ...

Levothyroxine — marketed under brand names such as Synthroid — is the second-most commonly prescribed medication among older adults in the US. It’s consumed by about 7% of the US population.

Findings showed a greater loss of total body bone mass and bone density in levothyroxine users compared with non-users. Treatment with levothyroxine may result in bone loss in older patients ...

The dosage can vary depending on what condition the drug is used to treat. Levothyroxine intravenous (IV) injection is approved by the FDA to treat myxedema coma (a severe form of hypothyroidism ...

The injectable pacemaker was tested in zebrafish and chicken embryos, and was found to work as designed. The gel was of a consistency that let it adhere to the heart, without negatively affecting ...